Literature DB >> 1889452

Prolonged QT, atrioventricular block, and sudden death in the newborn: an electrophysiologic evaluation.

N Saoudi1, A Bozio, G Kirkorian, G Atallah, J Normand, P Touboul.   

Abstract

An electrophysiologic study was performed in the first month of life in a patient with the congenital long QT syndrome and spontaneous episodes of 2/1 atrioventricular block. The block could be reproduced by incremental atrial pacing, and its infrahisian location was associated with a prolongation of the refractoriness in the ventricular muscle itself. Surprisingly, intravenous propranolol aggravated this phenomenon by further prolonging the QT interval. Sudden death occurred shortly thereafter during Holter monitoring and was due to a sudden resumption of normal AV conduction after an episode of 2:1 block, immediately followed by ventricular fibrillation.

Entities:  

Mesh:

Year:  1991        PMID: 1889452     DOI: 10.1093/eurheartj/12.7.838

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

1.  Large-scale elucidation of drug response pathways in humans.

Authors:  Yael Silberberg; Assaf Gottlieb; Martin Kupiec; Eytan Ruppin; Roded Sharan
Journal:  J Comput Biol       Date:  2012-02       Impact factor: 1.479

Review 2.  Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?

Authors:  S Viskin; R Fish; D Zeltser; B Belhassen; K Heller; D Brosh; S Laniado; H V Barron
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

3.  Prenatal findings in patients with prolonged QT interval in the neonatal period.

Authors:  M Hofbeck; H Ulmer; E Beinder; E Sieber; H Singer
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

4.  Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response.

Authors:  E Schulze-Bahr; H Fenge; D Etzrodt; W Haverkamp; G Mönnig; H Wedekind; G Breithardt; H-G Kehl
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.